JA-Redacted.pdf

LOG #: 20-00027

Blood Bank-NMCSD Page 1 of 2 1 Nov 12

JUSTIFICATION AND APPROVAL

FOR OTHER THAN FULL AND OPEN COMPETITION

1. Contracting Activity.

This justification is executed by the Naval Medical Logistics Command (NMLC), Fort Detrick, MD, on behalf of the Navy to meet the requirements of Naval Medical Center San Diego (NMCSD).

2. Description of the Action Being Approved.

The Government intends on awarding a Firm, Fixed-Price (FFP) contract. Award of a contract on a sole source basis for blood, blood components, and specialized testing for screening units to provide needed blood and blood products for patients in support of NMCSD from San Diego Blood Bank, 3636 Gateway Center Ave. Ste. 100, San Diego, CA, 92102-4508 is anticipated.

3. Description of Supplies/Services.

The NMCSD Blood Bank has a requirement for blood, blood components, and specialized testing for screening units to provide needed blood and blood products for patients. Blood product delivery times at NMCSD are Monday through Sunday, 24-hours a day, including all holidays. Delivery timeline is as follows: within 4-hours for routine (and products with special requirements) [e.g., antigen negative, irradiated]) and 2-hours for emergent (no special requirements). Timeliness of specimen pick-up for routine (24-hrs) or urgent (2-hrs) will be dependent upon the initial serological results and medical condition of the patient for identifying compatible blood and blood products.

The Blood and blood products shall be delivered timely and products shall be free of defects in accordance with federal and industry standards per Food and Drug Administration (FDA) regulations and American Association of Blood Banks (AABB) standards. All blood and blood products shall be delivered with maximum possible expiration dates. In addition, maintain inventory of blood and blood products including red blood cells, frozen plasma products and platelet products for all ages of life and for varying medical conditions. Primary use of blood and blood products are as follows: average of 450 red blood cells annually (historically 46% O Negative and 47% O Positive); and an average of 300 platelets, single donor annually. Blood and blood products shall be packaged in validated containers to maintain adequate temperatures during transport. Contractor shall allow the return of unused blood and blood products that have not expired. Contractor shall pick-up patient specimens for reference laboratory testing and provide a final report for antibody and antigen testing used for identifying compatible blood and blood products and managing transfusion medicine requirements necessary for the care and treatment of the patient. The government anticipates a contract with a Five (5) year ordering period.

4. Statutory Authority Permitting Other Than Full and Open Competition.

The statutory exception permitting other than full and open competition for this acquisition is 41 U.S.C. 1901 (see also FAR 13.501(a)).

5. Rationale Justifying Use of Cited Statutory Authority.

SDBB is the only vendor in the local area who can provide the required products and do so within the timelines stated above for the NMCSD Blood Bank in order for them to provide the critical blood services for its patients.

6. Description of Efforts Made to Solicit Offers from as Many Offerors as Practicable.

Market research was conducted in January 2020. It included a search of the Internet using Google, GSA Advantage, and the ECRI Sourcebook. Vendors who can potentially provide these blood services include SDBB and American Red Cross (ARC). SDBB is local and can provide the required products while they are also being capable of meeting the time sensitive deadlines. ARC is currently utilized for providing blood and blood products that can’t be supplied by either the local Military Blood Donor Center or SDBB, however, they are not able to meet the time sensitive nature of the requirement due to their location to the facility. This requirement will be posted to betaSAM in accordance with FAR 5.201(b)(1)(i). A Notice of Intent (NOI) to sole source was posted on beta SAM from 26 May 2020 – 10 June 2020. Solicitation N6264520R0057 was posted to beta SAM for one (1) day from 30 June 2020 – 01 July 2020. No responses or challenges were received to any of these postings.

7. Determination of Fair and Reasonable Cost.

LOG #: 20-00027

Blood Bank-NMCSD Page 2 of 2 1 Nov 12

The Contracting Officer has determined the anticipated cost to the Government of the supplies covered by this J&A will be fair and reasonable.

8. Actions to Remove Barriers to Future Competition.

For the reasons set forth in Paragraph 5, NMLC has no plans at this time to compete future contacts for the types of supplies covered by this document. If another potential source emerges, NMLC will assess whether competition for future requirements is feasible. Future requirements will be synopsized in accordance with FAR 5.203.